Stay updated on Pembrolizumab Combo in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo in Lung Cancer Clinical Trial page.

Latest updates to the Pembrolizumab Combo in Lung Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe Revision label on the page updates from v3.6.3 to v3.6.4, signaling a new build of the page.SummaryDifference0.0%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe page's revision tag has been updated to v3.6.3, replacing the previous v3.6.2. This reflects a minor build/version update.SummaryDifference0.0%

- Check41 days agoChange DetectedRevision: v3.6.2 is shown on the page, indicating a new software build. No study content or user-facing information appears to be altered.SummaryDifference0.0%

- Check55 days agoChange DetectedThe page now shows recruitment status 'No longer looking for participants' and adds help sections such as How to Read a Study Record, Common Questions, and How to Join a Study. It also updates the Intervention/Treatment heading from the previous Interventions formatting and revises the page version to v3.6.0.SummaryDifference0.3%

- Check62 days agoChange DetectedThe page shows a new revision: v3.5.5 instead of v3.5.4, indicating a software release. No substantive study details or user-facing content appear to have changed.SummaryDifference0.0%

- Check84 days agoChange DetectedRevision tag updated from v3.5.3 to v3.5.4, indicating a minor maintenance update to the ClinicalTrials.gov entry.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab Combo in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Lung Cancer Clinical Trial page.